ABIOMED, Inc.
ABMD
Real-time BATS EXCHANGE - 09/24 04:28:06 pm
403.555USD
+5.18%
Prev.384.8800
Open381.0300
High401.3350
Low378.0000
Volume1 565 354
Financials
Sales 2019 771 M
EBIT 2019 218 M
R. net 2019 204 M
Tréso. 2019 533 M
Rend. 2019 -
P/E ratio 2019 85,66
P/E ratio 2020 80,02
EV / Sales 2019 21,7x
EV / Sales 2020 16,7x
Capitalization 17 272 M
Company
ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart.

It distributes its products under the Impella brand.

The company was founded in 1981 and is headquartered in Danvers, MA.
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2018-09-24 Investor Breakfast
Trading Rating :
Investor Rating :
Latest news
02:02pABIOMED : Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival
AQ
09/21ABIOMED : to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018
AQ
09/20ABIOMED : to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018
AQ
09/19ABIOMED : to Showcase Expanded FDA Indications and Next Generation Heart Recovery Products at TCT 2018
AQ
09/06ABIOMED : MILITARY $50,251 Federal Contract Awarded to Abiomed
AQ
08/28ABIOMED : MILITARY $25,126 Federal Contract Awarded to Abiomed
AQ
08/14ABIOMED : MILITARY $75,000 Federal Contract Awarded to Abiomed
AQ
08/14ABIOMED : MILITARY $75,377 Federal Contract Awarded to Abiomed
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance411446444
Spread/Res.-2,6%-10%-9,7%
Spread/Supp.12%15%41%
Support359347284